Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,400.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 4,750.00p
  • 52 Week Low: 2,200.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 16,776
  • Market Cap: £125.27m
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
23.06% below the market average23.06% below the market average23.06% below the market average23.06% below the market average23.06% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
1yr Revenue Growth
9.94% above the market average9.94% above the market average9.94% above the market average9.94% above the market average9.94% above the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
52.58% above the market average52.58% above the market average52.58% above the market average52.58% above the market average52.58% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
37.28% below the market average37.28% below the market average37.28% below the market average37.28% below the market average37.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
40.24% above the market average40.24% above the market average40.24% above the market average40.24% above the market average40.24% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Book Ratio
92.56% below the market average92.56% below the market average92.56% below the market average92.56% below the market average92.56% below the market average
76.74% below the sector average76.74% below the sector average76.74% below the sector average76.74% below the sector average76.74% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
68.64% below the market average68.64% below the market average68.64% below the market average68.64% below the market average68.64% below the market average
26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average
Price Chg 3m
67.87% below the market average67.87% below the market average67.87% below the market average67.87% below the market average67.87% below the market average
30.61% below the sector average30.61% below the sector average30.61% below the sector average30.61% below the sector average30.61% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
15.86% below the market average15.86% below the market average15.86% below the market average15.86% below the market average15.86% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Momentum 20
96.57% below the market average96.57% below the market average96.57% below the market average96.57% below the market average96.57% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
75.62% above the market average75.62% above the market average75.62% above the market average75.62% above the market average75.62% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
ROCE
80.21% above the market average80.21% above the market average80.21% above the market average80.21% above the market average80.21% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.28% above the market average91.28% above the market average91.28% above the market average91.28% above the market average91.28% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Forecast EPS
80.79% above the market average80.79% above the market average80.79% above the market average80.79% above the market average80.79% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.82% below the market average35.82% below the market average35.82% below the market average35.82% below the market average35.82% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
Operating Profit Loss
25.81% above the market average25.81% above the market average25.81% above the market average25.81% above the market average25.81% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
25.99% below the market average25.99% below the market average25.99% below the market average25.99% below the market average25.99% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Cash
11.53% below the market average11.53% below the market average11.53% below the market average11.53% below the market average11.53% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
74.56% below the market average74.56% below the market average74.56% below the market average74.56% below the market average74.56% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,400.00p
Change Today 50.00p
% Change 2.13 %
52 Week High 4,750.00p
52 Week Low 2,200.00p
Volume 16,776
Shares Issued 5.22m
Market Cap £125.27m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Price Trend
72.7% below the market average72.7% below the market average72.7% below the market average72.7% below the market average72.7% below the market average
34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average
Income
40.81% above the market average40.81% above the market average40.81% above the market average40.81% above the market average40.81% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
26% below the market average26% below the market average26% below the market average26% below the market average26% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 07-Apr-2025

Time Volume / Share Price
17:06 250 @ 2,400.00p
16:45 100 @ 2,400.00p
16:11 120 @ 2,441.00p
15:33 250 @ 2,500.00p
15:29 500 @ 2,490.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page